Superworth

LivaNova profit margin LIVN

Gross, operating and net profit as a share of revenue over the last twelve months, from 2014.

Net margin, 12 months
12.8%
Operating margin, 12 months
12.7%
Net margin on a year earlier
+29.0 pts
Peer median
9.4%

Over the twelve months to Jun 30, 2026, LivaNova kept 12.8% of its revenue as net profit, with an operating margin of 12.7% and a gross margin of 68.1%.

Five years earlier its net margin was −37.5%.

The median for 6 medical device stocks of a similar size is 9.4%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−17.5%14.4%67.7%
FY20245.0%10.3%68.8%
FY20231.5%−5.9%66.9%
FY2022−8.4%−7.5%69.2%
FY2021−13.1%−0.1%68.2%
FY2020−37.3%−29.3%63.7%
FY2019−14.3%−15.6%70.2%
FY2018−17.1%−22.4%67.4%
FY2017−2.5%9.5%64.4%
FY2016−6.5%3.3%58.0%
FY2015n/an/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY2612.8%+29.0 pts12.7%
Q1 FY267.5%+24.9 pts13.4%
Q4 FY25−17.5%−22.5 pts14.4%
Q3 FY25−16.1%−18.0 pts14.4%
Q2 FY25−16.1%−14.8 pts13.4%
Q1 FY25−17.4%−14.7 pts12.7%
Q4 FY245.0%+3.5 pts10.3%
Q3 FY241.9%+1.7 pts0.3%
Q2 FY24−1.4%+7.6 pts−2.2%
Q1 FY24−2.7%+5.2 pts−4.2%
Q4 FY231.5%+10.0 pts−5.9%
Q3 FY230.3%+9.4 pts3.0%

Against its peers

Companies in Medical - Devices nearest LivaNova's size, closest first, today.

CompanyProfit margin
LIVNLivaNova12.8%
ITGRInteger7.0%
TMDXTransMedics22.7%
CNMDCONMED4.1%
ZBHZimmer Biomet9.5%
DXCMDexCom20.1%
GEHCGE HealthCare Technologies9.3%
Peer median9.4%

Where LivaNova ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on LivaNova

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.